Dicerna Pharmaceuticals Inc
Dicerna Pharmaceuticals Inc (DRNA) is a publicly traded company in the Unknown sector. Across all available filings, 40 corporate insiders have executed 434 transactions totaling $299.9M, demonstrating a bearish sentiment with -$222.5M in net insider flow. The most recent transaction on Dec 28, 2021 involved a transaction of 6,973 shares valued at $266.7K.
DRNA Insider Activity Summary
Who Is Buying DRNA Stock?
No significant insider buying has been recorded for DRNA in the recent period.
Who Is Selling DRNA Stock?
No significant insider selling has been recorded for DRNA in the recent period.
Is Dicerna Pharmaceuticals Inc Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for DRNA is bearish with an Insider Alignment Score of 13/100 and a net flow of -$222.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
DRNA Frequently Asked Questions
Understanding DRNA Insider Activity
Insider trading at Dicerna Pharmaceuticals Inc (DRNA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 40 insiders are actively trading DRNA stock, having executed 434 transactions in the past 90 days. The most active insider is Adam Koppel (Executive), who has made 5 transactions totaling $178.4M.
Related Tools
Track Dicerna Pharmaceuticals Inc Insider Activity
Get notified when executives and directors at DRNA file new Form 4 transactions